B Bannwarth

6.9k total citations · 1 hit paper
185 papers, 3.9k citations indexed

About

B Bannwarth is a scholar working on Pharmacology, Rheumatology and Surgery. According to data from OpenAlex, B Bannwarth has authored 185 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Pharmacology, 36 papers in Rheumatology and 29 papers in Surgery. Recurrent topics in B Bannwarth's work include Inflammatory mediators and NSAID effects (48 papers), Analytical Chemistry and Chromatography (18 papers) and Rheumatoid Arthritis Research and Therapies (18 papers). B Bannwarth is often cited by papers focused on Inflammatory mediators and NSAID effects (48 papers), Analytical Chemistry and Chromatography (18 papers) and Rheumatoid Arthritis Research and Therapies (18 papers). B Bannwarth collaborates with scholars based in France, Belize and United States. B Bannwarth's co-authors include Fabienne Péhourcq, Thierry Schaeverbeke, Marie Kostine, P. Netter, J Dehais, Laurence Labat, Christophe Richez, F. Lapicque, A Gaucher and Francis Blotman and has published in prestigious journals such as Journal of Clinical Microbiology, Annals of the Rheumatic Diseases and Biochemical Pharmacology.

In The Last Decade

B Bannwarth

172 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Fibromyalgia: A Survey in Five European Countries

2009 528 citations B Bannwarth et al. profile →

Peers

Countries citing papers authored by B Bannwarth

Since Specialization

Citations

This map shows the geographic impact of B Bannwarth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Bannwarth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Bannwarth more than expected).

Fields of papers citing papers by B Bannwarth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Bannwarth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Bannwarth. The network helps show where B Bannwarth may publish in the future.

Co-authorship network of co-authors of B Bannwarth

This figure shows the co-authorship network connecting the top 25 collaborators of B Bannwarth. A scholar is included among the top collaborators of B Bannwarth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Bannwarth. B Bannwarth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study 2017 ·Annals of the Rheumatic Diseases ·Marie Kostine, L. Rouxel, Thomas Barnetche, Rémi Veillon, Florent Martin, Caroline Dutriaux, L. Dousset, Anne Pham‐Ledard, S. Prey, M. Beylot‐Barry, (unknown), Marine Gross‐Goupil, (unknown), Alain Ravaud, Édouard Forcade, B Bannwarth, Marie‐Elise Truchetet, Christophe Richez, Nadia Mehsen, Thierry Schaeverbeke	208
2	Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry 2016 ·Arthritis Research & Therapy ·Marie‐Elise Truchetet, (unknown), Thomas Barnetche, (unknown), Jacques‐Eric Gottenberg, B Bannwarth, Christophe Richez, Thierry Schaeverbeke	10
3	Food and Drug Interactions 2015 ·World review of nutrition and dietetics ·René Royer, G Debry, (unknown), B Bannwarth	0
4	Clinical safety of tocilizumab in rheumatoid arthritis 2010 ·Expert Opinion on Drug Safety ·B Bannwarth, Christophe Richez	38
5	Acetaminophen or NSAIDs for the treatment of osteoarthritis 2006 ·Best Practice & Research Clinical Rheumatology ·B Bannwarth	38
6	Measuring the contribution of pharmacological treatment to advice to stay active in patients with subacute low-back pain: a randomised controlled trial 2005 ·Pharmacoepidemiology and Drug Safety ·Michel Rossignol, François‐André Allaert, Serge Rozenberg, Jean‐Pierre Valat, Bernard Avouac, (unknown), Gwénaël Le Teuff, B Bannwarth	9
7	Potential of immobilized artificial membrane chromatography for lipophilicity determination of arylpropionic acid non-steroidal anti-inflammatory drugs 2003 ·Journal of Pharmaceutical and Biomedical Analysis ·Fabienne Péhourcq, Christian Jarry, B Bannwarth	22
8	Adverse Events Associated with Rofecoxib Therapy 2003 ·Drug Safety ·B Bannwarth, (unknown), Liana Euller‐Ziegler, (unknown), Philippe Ravaud, Maxime Dougados	11
9	Effets indésirables médicamenteux observés dans des Services d’Accueil et d’Urgences français (Étude prospective de l’APNET et propositions pour des mesures préventives) 2003 ·Bulletin de l Académie Nationale de Médecine ·Patrice Queneau, B Bannwarth, Françoise Carpentier, J.M. Guliana, J. Bouget, Béatrice Trombert, Xavier Leverve	21
10	Fondaparinux Sodium Does Not Cross the Placental Barrier* 2002 ·Clinical Pharmacokinetics ·F. Lagrange, J.-L. Brun, (unknown), F Paolucci, (unknown), J. J. Leng, (unknown), B Bannwarth	19
11	Inhibiteurs sélectifs de COX-2 : AINS et estomac enfin réconciliés ? 2001 ·Gastroentérologie Clinique et Biologique ·B Bannwarth	2
12	Piroxicam concentrations in plasma and synovial fluid after a single dose of piroxicam-b-cyclodextrin 2001 ·International Journal of Clinical Pharmacology and Therapeutics ·B Bannwarth, Philippe Bertin, Fabienne Péhourcq, T. Schaeverbeke, Pierre Gillet, Gaëlle Lefrançois, (unknown), J Dehais, P. Netter, A Gaucher	11
13	Effect of dimethicone (polysilane gel) on the stereoselective pharmacokinetics of ketoprofen 1998 ·European Journal of Clinical Pharmacology ·Nathalie Presle, F. Lapicque, Pierre Gillet, (unknown), B Bannwarth, P. Netter	4
14	Analgésiques non morphiniques : Principes et règles d'utilisation 1996 ·La Revue du praticien ·B Bannwarth	1
15	Influence of lipophilicity on the diffusion of cephalosporins into the cerebrospinal fluid 1996 ·Fundamental and Clinical Pharmacology ·(unknown), Fabienne Péhourcq, G. Tramu, (unknown), B Bannwarth	21
16	Pharmacological aspects of chiral nonsteroidal anti‐inflammatory drugs 1990 ·Fundamental and Clinical Pharmacology ·(unknown), E. Payan, F. Lapicque, B Bannwarth, P. Netter	39
17	Recent Findings on the Pharmacokinetics of Non-Steroidal Anti-Inflammatory Drugs in Synovial Fluid 1989 ·Clinical Pharmacokinetics ·Patrick Netter, B Bannwarth, (unknown)	47
18	The effect of food on the systemic availability of ketoprofen 1988 ·European Journal of Clinical Pharmacology ·B Bannwarth, F. Lapicque, P. Netter, (unknown), (unknown), (unknown), R J Royer	20
19	Quelle pharmacovigilance pour un anti-inflammatoire non stéroïdien? 1987 ·La Presse Médicale ·(unknown), B Bannwarth, René Royer	1
20	Ostéite tuberculeuse du sternum. 1982 ·J.-L. Kuntz, (unknown), (unknown), B Bannwarth, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact